erythromycin has been researched along with cephalexin in 69 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (50.72) | 18.7374 |
1990's | 11 (15.94) | 18.2507 |
2000's | 13 (18.84) | 29.6817 |
2010's | 8 (11.59) | 24.3611 |
2020's | 2 (2.90) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Grime, K; Paine, SW | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Deguchi, K | 1 |
Laxer, RM; Mackay, E; Marks, MI | 1 |
Marks, MI | 1 |
Harris, RJ; Harris, RL | 1 |
Canos, HJ; Jeffery, JR; Ronald, AR | 1 |
Friedman, P; Greenblatt, DJ; Pfeifer, HJ | 1 |
Clahsen, JC; Ginsburg, CM; McCracken, GH; Thomas, ML | 1 |
Clements, HM; Hartley, CL; Linton, KB | 1 |
Ezaki, T; Imamura, H; Kobata, S; Ninomiya, K; Suzuki, S; Ueno, K; Watanabe, I; Watanabe, K | 1 |
Kisch, AL | 1 |
Asamura, Y; Kamishima, K; Kanai, M; Kawakami, Y; Matsumoto, H | 1 |
Curry, JT; Zallen, RD | 1 |
Emerson, BB; Harding, AL; Smith, AL; Smith, DH | 1 |
Barrett-Connor, E | 1 |
Begent, RH; Lambert, HP; O'Grady, FW | 1 |
Durack, DT; Pelletier, LL; Petersdorf, RG | 1 |
Nishino, T | 1 |
Hossack, G; Paddock, G; Parsons, RL | 1 |
Wilkinson, PM | 1 |
Mallory, SB | 1 |
Kiani, R | 1 |
al-Shibib, AS; Kandela, SA | 1 |
Hrabovszky, T; Sebök, B | 1 |
Bass, JW; Browning, WC; Demidovich, CW; Ruff, ME; Wittler, RR | 1 |
Doern, GV; Jorgensen, JH; Maher, LA; Preston, DA; Redding, JS; Thornsberry, C; Tubert, T | 1 |
Ahronheim, G; Bergeron, MG; Bouchard, M; Bryer, D; Cron, C; Dempsey, EE; Macdonald, N; Richard, JE; Riding, K; Young, J | 1 |
Chakhava, OV; Gorskaia, EM; Lapchinskaia, AV; Shenderov, BA; Trapezov, EV | 1 |
Chakhava, OV; Gorskaia, EM; Lapchinskaia, AV; Shenderov, BA | 1 |
Armstrong, JA; Goodwin, CS; Wee, SH; Wilson, DH | 1 |
Dekio, S; Hirata, T; Jidoi, J; Ohno, H; Ozasa, S | 1 |
Nord, CE; Wadström, T | 1 |
Hirayama, A; Iimura, I; Shimizu, H; Tomisawa, I; Yamaguchi, T | 1 |
Kornguth, ML; Kunin, CM; Monson, RA | 1 |
Brazeau, M; MacKenzie, R; Marks, MI; Rabinovitch, M | 1 |
Andrews, J; Williams, JD | 1 |
Pagano, JS; Sarubbi, FA | 1 |
Walker, AR | 1 |
Fairley, KF | 1 |
Wiedemann, B | 1 |
Trujillo, H | 1 |
Bergeron, JM; Girard, D; Milisen, WB; Retsema, JA | 1 |
El-Chaar, GM; Rubin, LG; Samulak, KM | 1 |
El-Chaar, GM; Mardy, G; Rubin, LG; Wehlou, K | 1 |
Groleau, EG; Kleemann, RL; Rigsbee, DR; Stephenson, GA; Xu, W | 1 |
Hoover, J | 1 |
Gizatullina, ED; Guryleva, ME; Ozol, SM; Vizel', AA | 1 |
Bryant, J; Gisby, J | 1 |
Rose, GE; Vardy, SJ | 1 |
Mant, A | 1 |
Kawabata, M; Li, M; Masuzawa, T; Wang, J; Yanagihara, Y | 1 |
Banaszczyk-Ruś, M; Grzybowska, W; Tyski, S | 1 |
Chung, JH; Clock, CA; Ehsanipoor, RM; McNulty, JA; Wing, DA | 1 |
Paasche, SR | 1 |
Lam, JC; Lam, PK; Leung, HW; Martin, M; Minh, TB; Murphy, MB; Richardson, BJ; So, MK | 1 |
Deng, S; Huang, J; Lu, S; Qiu, Z; Sui, Q; Wang, B; Yu, G; Zhao, W | 1 |
Lanier, J; Qui, MK; Shim, J | 1 |
da Cunha, CCRF; da Fonseca Santiago, A; da Silva Rodrigues, DA; de Barros, ALC; de Cássia Franco Afonso, RJ; de Queiroz Silva, S; do Espirito Santo, DR; Pereira, AR | 1 |
Ábrahám, H; Albert, B; Kilár, A; Kilár, F; Kocsis, B; Makszin, L; Nagy, L; Sándor, V; Urbán, P | 1 |
3 review(s) available for erythromycin and cephalexin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current status of the treatment of syphilis.
Topics: Cephalexin; Cephaloridine; Cephalosporins; Chloramphenicol; Drug Hypersensitivity; Erythromycin; Female; Fever; Fluorescent Antibody Technique; Follow-Up Studies; Humans; Neurosyphilis; Penicillin G Benzathine; Penicillins; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, First; Syphilis; Syphilis Serodiagnosis; Syphilis, Cardiovascular; Syphilis, Congenital; Syphilis, Latent; Tetracycline; Treponema pallidum; United States | 1975 |
Clinical inquiry: what is the best treatment for impetigo ?
Topics: Administration, Topical; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Local; Bacitracin; Bridged Bicyclo Compounds, Heterocyclic; Cephalexin; Clindamycin; Cloxacillin; Dicloxacillin; Diterpenes; Erythromycin; Fusidic Acid; Gentamicins; Humans; Impetigo; Meta-Analysis as Topic; Mupirocin; Randomized Controlled Trials as Topic | 2014 |
7 trial(s) available for erythromycin and cephalexin
Article | Year |
---|---|
Azithromycin compared with cephalexin in the treatment of skin and skin structure infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Cephalexin; Drug Administration Schedule; Erythromycin; Humans; Middle Aged; Skin Diseases, Infectious; Staphylococcal Infections; Streptococcal Infections | 1991 |
Double-blind, double-dummy comparison of azithromycin and cephalexin in the treatment of skin and skin structure infections.
Topics: Abscess; Adolescent; Adult; Aged; Aged, 80 and over; Azithromycin; Cellulitis; Cephalexin; Double-Blind Method; Drug Administration Schedule; Erythromycin; Female; Humans; Impetigo; Male; Middle Aged; Skin Diseases, Infectious; Wound Infection | 1991 |
Impetigo. Current etiology and comparison of penicillin, erythromycin, and cephalexin therapies.
Topics: Adolescent; Cephalexin; Child; Child, Preschool; Erythromycin; Female; Humans; Impetigo; Infant; Male; Microbial Sensitivity Tests; Penicillins; Random Allocation; Staphylococcal Infections; Streptococcal Infections | 1990 |
Comparative efficacies of erythromycin-sulfisoxazole and cefaclor in acute otitis media: a double blind randomized trial.
Topics: Acute Disease; Adolescent; Ampicillin; Anti-Bacterial Agents; Cefaclor; Cephalexin; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Combinations; Erythromycin; Female; Haemophilus influenzae; Humans; Infant; Male; Moraxella; Otitis Media with Effusion; Prospective Studies; Random Allocation; Recurrence; Streptococcus pneumoniae; Sulfisoxazole | 1987 |
Randomized, double blind comparison of brand and generic antibiotic suspensions: I. A study of taste in adults.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Cephalexin; Double-Blind Method; Drug Compounding; Drug Therapy, Combination; Drugs, Generic; Erythromycin; Erythromycin Ethylsuccinate; Female; Humans; Male; Middle Aged; Penicillin V; Smell; Sulfisoxazole; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Randomized, double blind comparison of brand and generic antibiotic suspensions: II. A study of taste and compliance in children.
Topics: Adolescent; Anti-Bacterial Agents; Cephalexin; Child; Child, Preschool; Double-Blind Method; Drug Compounding; Drug Therapy, Combination; Drugs, Generic; Erythromycin; Female; Humans; Male; Patient Compliance; Patient Satisfaction; Sulfisoxazole; Taste; Trimethoprim, Sulfamethoxazole Drug Combination | 1996 |
Prevention of cellulitis after open lacrimal surgery: a prospective study of three methods.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cefuroxime; Cellulitis; Cephalexin; Cephalosporins; Dacryocystorhinostomy; Erythromycin; Female; Humans; Intraoperative Care; Male; Middle Aged; Postoperative Care; Prospective Studies; Therapeutic Irrigation | 2000 |
59 other study(ies) available for erythromycin and cephalexin
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Species differences in biliary clearance and possible relevance of hepatic uptake and efflux transporters involvement.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Bile; Body Weight; Dogs; Drug Administration Routes; Humans; Liver; Membrane Transport Proteins; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Organic Anion Transporters; Pharmaceutical Preparations; Protein Binding; Rats; Species Specificity | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[In vitro examination on antibacterial activity of ciclacillin (ACPC) against clinically isolated strains (author's transl)].
Topics: Amoxicillin; Cephalexin; Cyclacillin; Erythromycin; Escherichia coli; Leucomycins; Penicillin Resistance; Penicillins; Staphylococcus aureus; Streptococcus pneumoniae; Streptococcus pyogenes | 1977 |
Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
Topics: Ampicillin; Anti-Bacterial Agents; Bacteria; Carbenicillin; Cephalexin; Cloxacillin; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Kanamycin; Klebsiella; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance; Polymyxins; Pseudomonas; Staphylococcus; Tobramycin | 1975 |
In vitro activity of clindamycin and other antimicrobials against gram-positive bacteria and Hemophilus influenzae.
Topics: Ampicillin; Bacteria; Cephalexin; Clindamycin; Cloxacillin; Drug Synergism; Erythromycin; Haemophilus influenzae; Lincomycin; Microbial Sensitivity Tests; Penicillin G; Staphylococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Sulfamethoxazole; Sulfisoxazole; Sulfonamides | 1975 |
Multiple antibiotic allergies.
Topics: Adolescent; Anti-Bacterial Agents; Cephalexin; Drug Hypersensitivity; Erythromycin; Female; Humans; Lincomycin; Tetracycline | 1978 |
Legionnaires' disease in a renal transplant recipient.
Topics: Adult; Cephalexin; Erythromycin; Humans; Kidney Failure, Chronic; Kidney Transplantation; Legionnaires' Disease; Male; Penicillins; Postoperative Complications; Radiography; Transplantation, Homologous | 1979 |
Effects of three antibiotics on theophylline kinetics.
Topics: Adult; Aminophylline; Cephalexin; Drug Interactions; Erythromycin; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Tetracycline; Theophylline | 1979 |
Pharmacologic evaluation of orally administered antibiotics in infants and children: effect of feeding on bioavailability.
Topics: Administration, Oral; Ampicillin; Animals; Anti-Bacterial Agents; Biological Availability; Cephalexin; Child, Preschool; Eating; Erythromycin; Humans; Infant; Milk; Penicillins; Saliva; Tears | 1978 |
Effects of cephalexin, erythromycin and clindamycin on the aerobic Gram-negative faecal flora in man.
Topics: Administration, Oral; Cephalexin; Citrobacter; Clindamycin; Drug Resistance, Microbial; Enterobacter; Erythromycin; Feces; Gram-Negative Aerobic Bacteria; Humans; Pseudomonas | 1978 |
[Josamycin: antibacterial activity against anaerobes (author's transl)].
Topics: Anti-Bacterial Agents; Bacteroides; Cefazolin; Cephalexin; Cephaloridine; Clindamycin; Drug Resistance, Microbial; Erythromycin; Fusobacterium; Leucomycins; Lincomycin | 1978 |
Principles of the antimicrobial therapy of head and neck infections.
Topics: Acute Disease; Antibiotics, Antitubercular; Bacterial Infections; Cephalexin; Chronic Disease; Clindamycin; Drug Combinations; Erythromycin; Gentamicins; Humans; Methods; Minocycline; Otorhinolaryngologic Diseases; Penicillins; Streptomycin; Tobramycin | 1976 |
Sensitivity of fresh isolates of Haemophilus to current antibiotics.
Topics: Anti-Bacterial Agents; Cephalexin; Chloramphenicol; Erythromycin; Gentamicins; Haemophilus; Humans; Kanamycin; Keratoconjunctivitis; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Streptomycin; Tetracyclines | 1975 |
A study of antibiotic usage in compound mandibular fractures.
Topics: Anti-Bacterial Agents; Bacterial Infections; Cephalexin; Clindamycin; Erythromycin; Female; Fracture Fixation; Fracture Fixation, Internal; Fractures, Ununited; Humans; Lincomycin; Male; Mandibular Diseases; Mandibular Fractures; Osteomyelitis; Penicillins; Postoperative Complications; Splints; Tooth Extraction | 1975 |
Hemophilus influenzae type B susceptibility to 17 antibiotics.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; Cefazolin; Cephalexin; Cephaloridine; Cephalothin; Cephradine; Chloramphenicol; Clindamycin; Culture Media; Erythromycin; Gentamicins; Haemophilus influenzae; Kanamycin; Penicillin G; Penicillin Resistance; Rifampin; Tetracycline | 1975 |
Sensible prescribing. III. Acute otitis media and sore throat.
Topics: Amphotericin B; Ampicillin; Anti-Bacterial Agents; Aspirin; Cephalexin; Drug Prescriptions; Erythromycin; Haemophilus influenzae; Humans; Metronidazole; Nystatin; Otitis Media; Penicillins; Pharyngitis; Staphylococcus; Streptococcus pyogenes | 1975 |
Chemotherapy of experimental streptococcal endocarditis. IV. Further observations on prophylaxis.
Topics: Ampicillin; Animals; Anti-Bacterial Agents; Cefazolin; Cephalexin; Clindamycin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Endocarditis, Bacterial; Erythromycin; Female; Injections, Intramuscular; Injections, Intravenous; Male; Penicillin G; Penicillin G Benzathine; Penicillin G Procaine; Rabbits; Streptococcus; Streptomycin; Vancomycin | 1975 |
An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus.
Topics: Bacterial Proteins; Cell Wall; Cephalexin; Drug Antagonism; Erythromycin; Staphylococcus aureus | 1975 |
The absorption of antibiotics in adult patients with coeliac disease.
Topics: Adult; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Celiac Disease; Cephalexin; Clindamycin; Erythromycin; Ethics, Medical; Fusidic Acid; Humans; Intestinal Absorption; Lincomycin; Pivampicillin; Rifampin; Sulfamethoxazole; Trimethoprim | 1975 |
Clinical pharmacology of antibiotic therapy.
Topics: Aminoglycosides; Amoxicillin; Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalexin; Cephaloridine; Cephalothin; Chloramphenicol; Clindamycin; Cloxacillin; Creatinine; Drug Therapy, Combination; Erythromycin; Floxacillin; Gentamicins; Humans; Kidney Diseases; Lincomycin; Methicillin; Penicillin G; Penicillins; Tetracyclines | 1976 |
Kinetics of haemolytic activity in Proteus strains.
Topics: Cephalexin; Erythromycin; Hemolysin Proteins; Hemolysis; Proteus; Spectrophotometry | 1990 |
[Acne fulminans].
Topics: Acne Vulgaris; Adjuvants, Immunologic; Anti-Inflammatory Agents, Non-Steroidal; Cephalexin; Child; Dermatitis, Seborrheic; Drug Therapy, Combination; Erythromycin; Humans; Isotretinoin; Male; Prednisolone | 1990 |
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefamandole; Cephalexin; Cephalothin; Chloramphenicol Resistance; Drug Combinations; Drug Resistance, Microbial; Erythromycin; Haemophilus influenzae; Humans; Rifampin; Sulfamethoxazole; Tetracycline Resistance; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination; United States | 1988 |
[The adhesive capacity of representative intestinal microflora in the continuous and split oral administration of cephalexin and erythromycin].
Topics: Administration, Oral; Animals; Bacteria; Bacterial Adhesion; Cephalexin; Drug Resistance, Microbial; Erythromycin; Escherichia coli; Intestines; Klebsiella; Methods; Rats; Staphylococcus aureus; Time Factors | 1987 |
[Changes in the microflora of the large intestine in rats administered cephalexin and erythromycin orally].
Topics: Administration, Oral; Animals; Cephalexin; Dipeptides; Ecology; Erythromycin; Feces; Female; Intestine, Large; Microbial Sensitivity Tests; Rats; Rats, Inbred F344; Time Factors | 1987 |
Response of Campylobacter pyloridis to antibiotics, bismuth and an acid-reducing agent in vitro--an ultrastructural study.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agents; Campylobacter; Cell Wall; Cephalexin; Cimetidine; Clindamycin; Erythromycin; Metronidazole; Microscopy, Electron; Organometallic Compounds; Penicillin G | 1987 |
Antibiotic susceptibilities of Staphylococcus aureus strains derived from furuncle and bullous impetigo.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalexin; Chloramphenicol; Erythromycin; Furunculosis; Humans; Impetigo; Penicillin Resistance; Skin Diseases, Vesiculobullous; Staphylococcus aureus; Tetracycline | 1985 |
Susceptibility of haemolytic oral enterococci to eight antibiotics in vitro.
Topics: Ampicillin; Anti-Bacterial Agents; Cephalexin; Enterococcus faecalis; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbial Sensitivity Tests; Penicillin G; Periapical Abscess; Periapical Tissue; Periodontitis; Pulpitis; Tetracycline | 1973 |
[Antibiotic therapy of scarlet fever].
Topics: Adolescent; Anti-Bacterial Agents; Cephalexin; Child; Child, Preschool; Clindamycin; Erythromycin; Humans; Scarlet Fever | 1973 |
Binding of antibiotics to a soluble protein from rat liver.
Topics: Amino Acids; Animals; Anti-Bacterial Agents; Carbon Radioisotopes; Cephalexin; Cephalothin; Chloramphenicol; Chromatography, Gel; Chromatography, Ion Exchange; Erythromycin; Lincomycin; Liver; Liver Extracts; Male; Minocycline; Nitrofurantoin; Penicillin G; Polymyxins; Protein Binding; Rats; Tetracycline | 1974 |
Treatment of Streptococcal Pharyngitis. II. In vitro studies of antibacterial activity.
Topics: Anti-Bacterial Agents; Cephalexin; Erythromycin; Humans; In Vitro Techniques; Lincomycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pharyngitis; Pharynx; Streptococcal Infections; Streptococcus | 1973 |
Sensitivity of Haemophilus influenzae to antibiotics.
Topics: Amines; Ampicillin; Anti-Bacterial Agents; Cephalexin; Cephaloridine; Cephalosporins; Cephalothin; Chloramphenicol; Clindamycin; Erythromycin; Haemophilus influenzae; Humans; Lincomycin; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Respiratory Tract Infections; Rifamycins; Sulfamethoxazole; Tetracycline; Trimethoprim | 1974 |
Pneumonia.
Topics: Ampicillin; Anti-Bacterial Agents; Bronchopneumonia; Cephalexin; Cephalothin; Erythromycin; Gentamicins; Haemophilus Infections; Humans; Klebsiella Infections; Lincomycin; Methicillin; Mycoplasma Infections; Penicillin G; Penicillins; Pneumonia; Pneumonia, Pneumococcal; Pneumonia, Staphylococcal; Pneumonia, Viral | 1972 |
Treatment of streptococcal pharyngitis.
Topics: Cephalexin; Erythromycin; Humans; Penicillins; Pharyngitis; Streptococcal Infections | 1973 |
Diagnosis and treatment of pyelonephritis.
Topics: Ampicillin; Bacterial Infections; Cephalexin; Erythromycin; Female; Gentamicins; Humans; Kidney Diseases; Leukocyte Count; Nalidixic Acid; Nitrofurantoin; Oxazoles; Pyelonephritis; Pyuria; Recurrence; Sulfonamides; Ureteral Diseases | 1973 |
[Comparison of the activity of cefaclor with amoxicillin, erythromycin and doxycycline in an in vitro model].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cephalexin; Doxycycline; Erythromycin; Escherichia coli; Microbial Sensitivity Tests; Time Factors | 1983 |
Cefadroxil monohydrate versus erythromycin in paediatric patients.
Topics: Cefadroxil; Cephalexin; Child; Child, Preschool; Erythromycin; Erythromycin Estolate; Female; Humans; Infant; Male; Otitis Externa; Otitis Media; Respiratory Tract Infections | 1981 |
Comparison of azithromycin, roxithromycin, and cephalexin penetration kinetics in early and mature abscesses.
Topics: Abscess; Animals; Azithromycin; Cephalexin; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Erythromycin; Male; Mice; Mice, Inbred Strains; Rats; Roxithromycin; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus aureus; Time Factors | 1993 |
Formation of isomorphic desolvates: creating a molecular vacuum.
Topics: Absorption; Calorimetry; Cefaclor; Cephalexin; Enalapril; Erythromycin; Models, Molecular; Molecular Structure; Powders; Solubility; Water; X-Ray Diffraction | 1998 |
"Antibiotic selection for endodontic infections".
Topics: Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cephalexin; Clindamycin; Dental Pulp Cavity; Dental Pulp Diseases; Erythromycin; Humans; Patient Care Planning; Penicillin V; Periapical Diseases | 1995 |
[Antibiotic sensitivity of pathogenic microflora: data of the bacteriological laboratory at the antituberculosis clinic].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Bacteria; Carbenicillin; Cefuroxime; Cephalexin; Cephalosporins; Chloramphenicol; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erythromycin; Female; Gentamicins; Humans; Inpatients; Lincomycin; Male; Microbial Sensitivity Tests; Neomycin; Outpatients; Oxacillin; Penicillins; Rifampin; Spiramycin; Streptomycin; Tetracycline | 1998 |
Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Topics: Administration, Oral; Administration, Topical; Animals; Anti-Bacterial Agents; Bacitracin; Cephalexin; Chemistry, Pharmaceutical; Cricetinae; Erythromycin; Female; Floxacillin; Fusidic Acid; Impetigo; Male; Mice; Mupirocin; Neomycin; Penicillins; Skin Diseases, Bacterial; Staphylococcal Infections; Staphylococcus; Streptococcal Infections; Streptococcus; Wound Infection | 2000 |
Choosing the most appropriate antibiotic for respiratory infections.
Topics: Adult; Amoxicillin-Potassium Clavulanate Combination; Australia; Cephalexin; Child, Preschool; Clinical Competence; Drug Utilization; Erythromycin; Family Practice; Female; Guidelines as Topic; Humans; Male; Practice Patterns, Physicians'; Respiratory Tract Infections | 2000 |
In-vitro and in-vivo antibiotic susceptibilities of Lyme disease Borrelia isolated in China.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Borrelia burgdorferi; Cephalexin; Cephalosporins; China; Erythromycin; Humans; In Vitro Techniques; Lyme Disease; Mice; Microbial Sensitivity Tests; Minocycline; Penicillins | 2000 |
[Interaction of aminoglycosides and the other antibiotic on selected bacterial strains].
Topics: Aminoglycosides; Amoxicillin; Anti-Bacterial Agents; Cephalexin; Dihydrostreptomycin Sulfate; Drug Antagonism; Drug Combinations; Drug Synergism; Erythromycin; Gentamicins; Kanamycin; Lincomycin; Penicillin G; Spectinomycin; Streptomycin | 2004 |
A retrospective review of ampicillin-sulbactam and amoxicillin + clavulanate vs cefazolin/cephalexin and erythromycin in the setting of preterm premature rupture of membranes: maternal and neonatal outcomes.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Cefazolin; Cephalexin; Chorioamnionitis; Clavulanic Acid; Drug Therapy, Combination; Endometritis; Enterocolitis, Necrotizing; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Pregnancy; Pregnancy Outcome; Retrospective Studies; Sulbactam | 2008 |
Rhodococcus equi infection in a surgical wound.
Topics: Actinomycetales Infections; Adult; Anti-Bacterial Agents; Bacteriological Techniques; Cephalexin; Drug Resistance, Bacterial; Erythromycin; Humans; Male; Retrospective Studies; Rhodococcus equi; Surgical Wound Infection | 2009 |
Distribution, fate and risk assessment of antibiotics in sewage treatment plants in Hong Kong, South China.
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cephalexin; China; Chloramphenicol; Drug Utilization; Environmental Monitoring; Erythromycin; Fluoroquinolones; Hong Kong; Humans; Macrolides; Ofloxacin; Risk Assessment; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Pollution, Chemical | 2012 |
Identification of priority pharmaceuticals in the water environment of China.
Topics: Anti-Bacterial Agents; Cephalexin; China; Diclofenac; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Ecosystem; Environmental Monitoring; Erythromycin; Humans; Ibuprofen; Ketoconazole; Pharmaceutical Preparations; Rivers; Waste Disposal, Fluid; Water Pollutants, Chemical; Water Purification | 2012 |
Removal of cephalexin and erythromycin antibiotics, and their resistance genes, by microalgae-bacteria consortium from wastewater treatment plant secondary effluents.
Topics: Anti-Bacterial Agents; Bacteria; Cephalexin; Erythromycin; Microalgae; Wastewater; Water Purification | 2021 |
The Effect of Mutation in Lipopolysaccharide Biosynthesis on Bacterial Fitness.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbohydrate Epimerases; Cephalexin; Erythromycin; Frameshift Mutation; Genetic Fitness; Genome, Bacterial; Lipopolysaccharides; Shigella sonnei | 2022 |